ory authorities, drug pricing, spending, insurance and reimbursement- Market analysis of segments such as prescription medicines, biotechnology and over-the-counter medicines- Competitive profiling of major domestic and international companies operating in the South Korea pharmaceutical market- Analyses of the licensing, partnership and M&A deals that took place between 2007 and 2012Reasons to buy